Abstract
AbstractThe control of endogenous protein activity with light inside live cells is helpful for the high spatiotemporal probing of their dynamic roles. Herein, we report the first small‐molecule‐ligand‐directed caging approach to control the endogenous human O6‐alkylguanine‐DNA alkyltransferase (AGT) activity with light, and the caged AGT is constructed from the native intracellular AGT. The photo‐responsive O6‐benzylguanine derivative O6‐NBG3 is developed to site‐specifically cage the AGT′s catalytic cysteine residue, and the light irradiation on‐demand restores AGT′s activity in vitro, in bacteria, and in mammalian cells. With O6‐NBG3, the alkylated AGT is dealkylated for the first time to recover the DNA repair activity in breast cancer MCF‐7 cells by the dose‐dependent light irradiation. This decaging strategy enables the localized modulation of endogenous AGT activity with high temporal precision without genetic engineering, which holds great potential for therapeutic applications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
